Embedded Files
Monday, May 20th
Monday, May 20th
12:30pm - 1:30pm
Mo2056: INFLIXIMAB AND VEDOLIZUMAB HAVE SIMILAR CLINICAL AND SAFETY OUTCOMES AMONG BIOLOGIC-NAÏVE PATIENTS WITH MILD TO MODERATE PEDIATRIC INFLAMMATORY BOWEL DISEASE.
Mo2056: INFLIXIMAB AND VEDOLIZUMAB HAVE SIMILAR CLINICAL AND SAFETY OUTCOMES AMONG BIOLOGIC-NAÏVE PATIENTS WITH MILD TO MODERATE PEDIATRIC INFLAMMATORY BOWEL DISEASE.
Format: Poster
Presenter: Essam Ibraheem Ahmed Elknawy - Stanford, Peds GI
Poster Number: 2056
Society: ASGE
Page updated
Report abuse